Galux
Galux develops an AI-based molecular design platform to identify and advance novel therapeutics for rare and incurable diseases. The company integrates machine learning with physics- and chemistry-based models to perform protein structure prediction, protein–protein interaction prediction, and protein–ligand interaction prediction. Its technology stems from 15 years of research and competitive performance in protein modeling benchmarks. Galux operates as a drug design platform and discovery partner for biopharma organizations, targeting early-stage therapeutic development.
Galux
Galux develops an AI-based molecular design platform to identify and advance novel therapeutics for rare and incurable diseases. The company integrates machine learning with physics- and chemistry-based models to perform protein structure prediction, protein–protein interaction prediction, and protein–ligand interaction prediction. Its technology stems from 15 years of research and competitive performance in protein modeling benchmarks. Galux operates as a drug design platform and discovery partner for biopharma organizations, targeting early-stage therapeutic development.